- Home
- TRST vs ARVN Comparison
TRST vs ARVN Comparison
Compare TRST & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- ARVN
- Stock Information
- Founded
- TRST 1902
- ARVN 2015
- Country
- TRST United States
- ARVN United States
- Employees
- TRST N/A
- ARVN N/A
- Industry
- TRST Major Banks
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- TRST Finance
- ARVN Health Care
- Exchange
- TRST Nasdaq
- ARVN Nasdaq
- Market Cap
- TRST 540.7M
- ARVN 456.2M
- IPO Year
- TRST N/A
- ARVN 2018
- Fundamental
- Price
- TRST $32.03
- ARVN $7.67
- Analyst Decision
- TRST
- ARVN Buy
- Analyst Count
- TRST 0
- ARVN 21
- Target Price
- TRST N/A
- ARVN $20.53
- AVG Volume (30 Days)
- TRST 78.2K
- ARVN 2.3M
- Earning Date
- TRST 07-21-2025
- ARVN 07-29-2025
- Dividend Yield
- TRST 4.49%
- ARVN N/A
- EPS Growth
- TRST N/A
- ARVN N/A
- EPS
- TRST 2.68
- ARVN N/A
- Revenue
- TRST $173,999,000.00
- ARVN $426,900,000.00
- Revenue This Year
- TRST $13.13
- ARVN $2.83
- Revenue Next Year
- TRST N/A
- ARVN N/A
- P/E Ratio
- TRST $11.96
- ARVN N/A
- Revenue Growth
- TRST N/A
- ARVN 498.74
- 52 Week Low
- TRST $26.14
- ARVN $5.90
- 52 Week High
- TRST $38.89
- ARVN $34.11
- Technical
- Relative Strength Index (RSI)
- TRST 58.41
- ARVN 55.28
- Support Level
- TRST $30.72
- ARVN $6.70
- Resistance Level
- TRST $31.48
- ARVN $8.24
- Average True Range (ATR)
- TRST 0.64
- ARVN 0.48
- MACD
- TRST 0.04
- ARVN 0.17
- Stochastic Oscillator
- TRST 86.11
- ARVN 72.20
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.